News
10-22-2012, 01:28 AM
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and The Institute of Photonic Sciences (ICFO) have collaborated on the development of a diagnostic tool that identifies the metastatic ability of breast cancer cells. The analysis is based on the characterization of the lipid component of the cells, which is indicative of malignancy...
More... (http://www.medicalnewstoday.com/releases/251735.php)
More... (http://www.medicalnewstoday.com/releases/251735.php)